Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Miners keep FTSE 100 afloat after hot inflation

Wed, 13th Apr 2022 12:02

(Alliance News) - The FTSE 100 was treading water around midday on Wednesday, following the third straight extraordinary inflation print of the week.

The UK consumer prices index rose by 7.0% in the 12 months to March 2022, advancing from February's 6.2% rise, data from the Office for National Statistics showed.

Wednesday's print is the highest 12-month inflation rate in the National Statistics series, which began in January 1997. It is also the highest rate in the historic modelled series since March 1992.

The UK inflation data followed two equally hot figures in Germany and the US on Tuesday.

US consumer prices were 8.5% higher in March on an annual basis, stepping up from the 7.9% increase seen in February. In Germany, inflation raced to 7.3% in March, ahead of the 5.1% figure seen in February.

The pound was quoted at USD1.3004 midday Wednesday, down from USD1.3037 at the London equities close on Tuesday - but has rebounded from trading around USD1.2974 just after the inflation print.

The FTSE 100 index was up just 6.11 points, or 0.1%, at 7,582.77 midday Wednesday. The mid-cap FTSE 250 index was down 126.61 points, or 0.6%, at 20,883.00, while the AIM All-Share index was down 2.80 points, or 0.3%, at 1,052.86.

The Cboe UK 100 index was flat at 755.13. The Cboe 250 was down 0.7% at 18,356.90, and the Cboe Small Companies down 0.1% at 15,396.27.

"The latest UK inflation figure makes for ugly reading, but it shouldn't really be a shock to the markets. If anything, inflation could get even worse from here," said Danni Hewson, financial analyst at AJ Bell.

"When investors see high inflation figures, they typically look to put money into companies that thrive in an inflationary environment. That includes miners, which might explain why the likes of Antofagasta, Glencore and Anglo American were among the top risers on the FTSE 100."

Both Glencore and Anto were up 1.3%, while Anglo was up 0.9%.

Miners were enjoying a green session despite disappointing data out of China. Imports shrank annually in March for the first time in nearly two years, official data showed Wednesday, hit by coronavirus lockdowns and weakening consumer demand.

The world's second-largest economy has stuck to a strict zero-Covid strategy as it tries to contain outbreaks fuelled by the Omicron variant in recent months.

Imports dropped 0.1% from a year ago, according to data from China's Customs Administration – the first such decline since August 2020, in the early phase of the pandemic. The figure was much lower than the forecast from a Bloomberg poll of economists, and a far cry from the 15.5% growth for the first two months this year.

Capital Economics said: "The latest trade data out of China suggest that recent restrictions imposed to contain the surge in new cases of Covid-19 are hitting commodity demand hard. And we think it will remain weak in the months ahead as activity in the commodity-intensive construction sector softens further."

China's export growth slowed as well in March to 14.7%, down from 16.3% in the first two months.

But positively, some residents of Shanghai were allowed out of their homes as the city of 25 million eased a two-week-old shutdown after a video posted online showed what was said to be people who ran out of food breaking into a supermarket.

About 6.6 million people can go outdoors, but some must stay in their own neighbourhoods, the online news outlet The Paper reported, citing city officials.

AJ Bell's Hewson added: "Equally, investors also look to avoid companies that could lose out from high inflation which includes consumer-facing businesses. Tesco's warning that profits could dip cast a chill across the supermarket sector. JD Sports and Next also saw their shares fall no doubt as investors speculated their sales could be weaker near-term if people have a lot less money to buy new trainers and clothes once they’ve paid their ever-increasing bills."

JD Sports was down 2.8%, while Next was 2.2% lower.

Tesco gave back 4.1%.

Shore Capital has cut its Tesco recommendation to 'hold' from 'buy', after the blue chip grocer guided for slowing growth in financial 2023.

Tesco warned of a hit to profit in the year ahead amid inflationary pressures and normalising consumer behaviour post-pandemic.

"Clearly, the external environment has become more challenging in recent months. Against a tough backdrop for our customers and with household budgets under pressure, we are laser-focused on keeping the cost of the weekly shop in check - working in close partnership with our suppliers, as well as doing everything we can to reduce our own costs," said Chief Executive Ken Murphy.

For financial 2023, Tesco is guiding for retail adjusted operating profit between GBP2.4 billion and GBP2.6 billion - which would be below the GBP2.65 billion registered in financial 2022. It gave the guidance "in the form of a wider than usual range" to reflect the uncertainties facing the business, such as inflation and normalising customer behaviour.

Tesco said it saw annual profit rise following a "strong performance" during the year to February 26, leading to the launch of a new GBP750 million share buyback.

Pretax profit ballooned to GBP2.03 billion from GBP636 million the year prior. Revenue rose 6% to GBP61.34 billion from GBP57.89 billion, as group sales increased 2.5% to GBP54.77 billion from GBP53.45 billion.

Peer Sainsbury was down 3.4% in a negative read-across.

Housebuilders in London were also struggling on Wednesday, grappling with cost-of-living concerns amid sky-high inflation as well as a UK government warning over housebuilders yet to sign a voluntary pledge to help fix unsafe cladding.

"The government is introducing new powers that allow enforcement on any remaining companies who fail to sign up, as well as those that breach the agreement they have signed up to. These new powers would allow the Secretary of State to block those who refuse to make and deliver on their commitments from building and selling new homes," the Department for Levelling Up, Housing and Communities said.

Taylor Wimpey gave back 2.5%, Barratt 2.4%, Persimmon 2.1% and Berkeley 1.5%.

Brent oil was quoted at USD106.47 a barrel on Wednesday morning, up against USD104.70 at the time of the equity market close in London on Tuesday.

London's oil majors followed the price of oil higher, with Shell up 1.5% and BP up 0.9%.

GlaxoSmithKline advanced 1.0% after it reached an agreement to acquire late-stage biopharmaceutical company Sierra Oncology Inc for USD1.9 billion.

California-based Sierra focuses on targeted therapies for the treatment of rare forms of cancer. GlaxoSmithKline said that the acquisition will complement its commercial and medical expertise in haematology - diseases related to blood. Further, it will support the development of its portfolio of new speciality medicines and vaccines.

GSK expects the deal to be accretive to adjusted earnings per share in 2024.

Stocks in New York were pointed to a positive open on Wednesday. The Dow Jones Industrial Average and S&P 500 were both called up 0.3%, and the Nasdaq Composite was seen opening 0.4% higher.

In mainland Europe, the CAC 40 in Paris was down 0.5%, while the DAX 40 in Frankfurt was down 0.9%.

The euro was priced at USD1.0825, down from USD1.0863.

Against the yen, the dollar was trading at JPY126.05 midday Wednesday, up from JPY125.14 on Tuesday. The Japanese yen was trading around a two-decade low, the currency in recent weeks hit by a perfect storm of US Federal Reserve tightening, a dovish Bank of Japan, and the Ukraine war's impact on oil prices.

Gold stood at USD1,979.30 an ounce, up against USD1,973.44 late Tuesday.

Still to come in Wednesday's economic calendar are US producer price figures at 1330 BST.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.